Christopher Sorli

Christopher Sorli has a strong background in the medical field, with extensive experience in roles such as Chief Medical Officer and Vice President of Medical Affairs. Christopher is currently serving as the Chief Medical Officer at Endogenex, where they are responsible for shaping the company's strategic medical vision and leading medical affairs activities. Prior to this, they worked as the Chief Medical Officer at Acerus Pharma from 2020 to 2023. Christopher also held several leadership positions at Sanofi, including Vice President of US Medical Affairs and Head of Cardio-Metabolism. Before joining Sanofi, they served as the Department Chair of Diabetes, Endocrinology, and Metabolism at Billings Clinic. Additionally, Christopher has experience in clinical research, having chaired expert panels for the DEVOTE and DUAL 8 trials. Christopher also held a teaching position as an Adjunct Clinical Professor at Rocky Mountain College.

Christopher Sorli has a diverse education history. Christopher pursued their Bachelor of Science (B.S.) degree in Chemical Engineering from Tufts University, graduating in 1984. Christopher then went on to complete a Medical Resident program in the Internal Medicine Residency Program at Beth Israel Hospital, Harvard Medical School from 1991 to 1994. Following this, they undertook a Fellowship in Endocrinology, Diabetes, and Metabolism at the University of Minnesota Hospital and Clinic, where they studied from 1994 to 1997. Lastly, Christopher Sorli earned their Doctor of Medicine (MD)/PhD degree in Immunology from UMass Chan Medical School. Further details about the duration of this program are not provided.